-
2 weeks ago | 
bloomberg.com | Sabrina Willmer |Jef Feeley
The brief is a response after Tesla, Musk and a group of shareholders appealed the December decision by Chancellor Kathaleen St. J. McCormick rejecting the chief executive’s award for the second time. (Bloomberg) -- A Tesla Inc. shareholder urged Delaware’s highest court to uphold a decision that struck down Elon Musk’s record-setting pay package, as the world’s richest person fights to recover it on appeal.
-
3 weeks ago | 
news.bloomberglaw.com | Sabrina Willmer |Jef Feeley
Red Tree Investments LLC was approved as the opening bidder for Citgo Petroleum Corp.’s parent company, jump-starting a new effort to attract higher offers that will help compensate creditors of Venezuela whose assets were seized. Judge Leonard Stark in Delaware on Monday signed off on a recommendation by a court-appointed adviser that puts the starting offer at about $3.7 billion.
-
3 weeks ago | 
claimsjournal.com | Jef Feeley |Sabrina Willmer
Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to trial over claims that the heartburn drug Zantac is linked to cancer.
-
3 weeks ago | 
detroitnews.com | Jef Feeley |Sabrina Willmer
Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to trial over claims that the heartburn drug Zantac is linked to cancer.
-
3 weeks ago | 
eu.detroitnews.com | Jef Feeley |Sabrina Willmer
Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to trial over claims that the heartburn drug Zantac is linked to cancer.
-
3 weeks ago | 
bloomberg.com | Jef Feeley |Sabrina Willmer
Zantac hit the US market as a prescription drug in 1983 before transforming into an over-the-counter heartburn treatment in 1995. (Bloomberg) -- Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to trial over claims that the heartburn drug Zantac is linked to cancer.
-
1 month ago | 
news.bloomberglaw.com | Jef Feeley
A Saudi princess embroiled in a long-running fight with her ex-husband over a $33 million Beverly Hills property says she’s a single mother of six and at this point can’t even afford a lawyer. “I am exhausted both financially, emotionally and psychologically,” Princess Fahdah Husain Abdulrahman Al Athel said in a filing about a seven-year battle over repairs to their 2.3-acre compound.
-
1 month ago | 
bloomberg.com | Jef Feeley
The two are fighting over this sprawling property at 76 Beverly Park Lane in Beverly Hills. (Bloomberg) -- A Saudi princess embroiled in a long-running fight with her ex-husband over a $33 million Beverly Hills property says she’s a single mother of six and at this point can’t even afford a lawyer. “I am exhausted both financially, emotionally and psychologically,” Princess Fahdah Husain Abdulrahman Al Athel said in a filing about a seven-year battle over repairs to their 2.3-acre compound.
-
1 month ago | 
insurancejournal.com | Jef Feeley
Billionaire investor Warren Buffett’s Duracell battery maker was accused by chemical producer BASF SE of stealing trade secrets about lithium ion battery technology. BASF, the world’s biggest chemical maker by revenue, claims in a lawsuit that Duracell, owned by Buffett’s Berkshire Hathaway since 2016 – misappropriated the technology while the companies had a cooperation agreement.
-
1 month ago | 
news.bloomberglaw.com | Jef Feeley
Billionaire investor Warren Buffett’s Duracell battery maker was accused by chemical producer BASF SE of stealing trade secrets about lithium ion battery technology. BASF, the world’s biggest chemical maker by revenue, claims in a lawsuit that Duracell, owned by Buffett’s Berkshire Hathaway since 2016 – misappropriated the technology while the companies had a cooperation agreement.
